Policy & Medicine
Legal, Regulatory, and Compliance Issues
Browsing daily archive
March 30, 2011
FDA Regulations Doubles Review Time and Quadruples Trial Size for Diabetes Therapies
Read more
IOM Clinical Practice Guidelines We Can Trust — But What About the IOM?
Read more